18301 Von Karman Avenue
AiVita Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AiVita Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its products and therapeutic pipeline.
CEO: Dr. Hans S. Keirstead Ph.D.
CMO: Robert O. Dillman, M.D.
CSO: Gabriel Nistor, M.D.
Please click here for AiVita's technology.
Please click here for AiVita's products.